legislation: 110-s-3633

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
110-s-3633 110 s 3633 Transparency in Drug Labeling Act Health 2008-09-26 2008-09-26 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Senate Sen. Brown, Sherrod [D-OH] OH D B000944 0 Transparency in Drug Labeling Act - Amends the Federal Food, Drug, and Cosmetic Act to deem a drug to be misbranded unless the labeling of such drug lists the identity of the country of manufacture of each active ingredient and each inactive ingredient of the drug, listed in descending order based on the percentage of the number of such ingredients in the final dosage form manufactured in such countries. 2022-02-03T05:09:49Z  

Links from other tables